Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Centrin 2 is required for mouse olfactory ciliary trafficking and development of ependymal cilia planar polarity.

The Journal of neuroscience : the official journal of the Society for Neuroscience | 2014

Centrins are ancient calmodulin-related Ca(2+)-binding proteins associated with basal bodies. In lower eukaryotes, Centrin2 (CETN2) is required for basal body replication and positioning, although its function in mammals is undefined. We generated a germline CETN2 knock-out (KO) mouse presenting with syndromic ciliopathy including dysosmia and hydrocephalus. Absence of CETN2 leads to olfactory cilia loss, impaired ciliary trafficking of olfactory signaling proteins, adenylate cyclase III (ACIII), and cyclic nucleotide-gated (CNG) channel, as well as disrupted basal body apical migration in postnatal olfactory sensory neurons (OSNs). In mutant OSNs, cilia base-anchoring of intraflagellar transport components IFT88, the kinesin-II subunit KIF3A, and cytoplasmic dynein 2 appeared compromised. Although the densities of mutant ependymal and respiratory cilia were largely normal, the planar polarity of mutant ependymal cilia was disrupted, resulting in uncoordinated flow of CSF. Transgenic expression of GFP-CETN2 rescued the Cetn2-deficiency phenotype. These results indicate that mammalian basal body replication and ciliogenesis occur independently of CETN2; however, mouse CETN2 regulates protein trafficking of olfactory cilia and participates in specifying planar polarity of ependymal cilia.

Pubmed ID: 24790208 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: NEI NIH HHS, United States
    Id: EY08123
  • Agency: NEI NIH HHS, United States
    Id: R01 EY019298
  • Agency: NIDCD NIH HHS, United States
    Id: DC011686
  • Agency: NIDCD NIH HHS, United States
    Id: DC002994
  • Agency: NEI NIH HHS, United States
    Id: EY014800-039003
  • Agency: NEI NIH HHS, United States
    Id: EY019298
  • Agency: NEI NIH HHS, United States
    Id: R01 EY008123
  • Agency: NIDCD NIH HHS, United States
    Id: F31 DC011686
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC002994
  • Agency: NEI NIH HHS, United States
    Id: P30 EY014800

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


CNGA1 and CNGA3 (antibody)

RRID:AB_10672374

This monoclonal targets CNGA1 and CNGA3

View all literature mentions